Market Research Logo

Arno Therapeutics, Inc. (ARNI) - Financial and Strategic SWOT Analysis Review

Arno Therapeutics, Inc. (ARNI) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Arno Therapeutics, Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the treatment of breast and endometrial cancer) with Invivis Pharmaceuticals, Inc.; AR-42 (for hematological malignancies and solid tumors); and AR-12, (for solid tumors and lymphoma) with the Ohio State University. These compounds are in clinical or preclinical stages of development. The company has agreements with pharmaceutical companies and research institutes to develop its product portfolio. Arno Therapeutics is headquartered in Flemington, New Jersey, the US.

Arno Therapeutics, Inc. Key Recent Developments

May 16, 2016: Arno Therapeutics Reports First Quarter 2016 Financial and Business Update
Mar 30, 2016: Arno Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update
Nov 16, 2015: Arno Therapeutics Reports Third Quarter 2015 Financial Results and Business Update
Aug 14, 2015: Arno Therapeutics Reports Second Quarter 2015 Financial Results
May 15, 2015: Arno Therapeutics Reports First Quarter 2015 Financial and Business Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Arno Therapeutics, Inc. - Key Facts
Arno Therapeutics, Inc. - Key Employees
Arno Therapeutics, Inc. - Key Employee Biographies
Arno Therapeutics, Inc. - Major Products and Services
Arno Therapeutics, Inc. - Pharmaceutical Pipeline Products Data
Arno Therapeutics, Inc., Pipeline Products by Therapy Area
Arno Therapeutics, Inc., Pipeline Products by Development Phase
Arno Therapeutics, Inc. - History
Arno Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Arno Therapeutics, Inc. - Business Description
Arno Therapeutics, Inc. - Corporate Strategy
Arno Therapeutics, Inc. - SWOT Analysis
SWOT Analysis - Overview
Arno Therapeutics, Inc. - Strengths
Strength - Research and Development Activities
Strength - Orphan Drug Designation
Arno Therapeutics, Inc. - Weaknesses
Weakness - History of Operating Losses
Weakness - Competitive Positioning
Arno Therapeutics, Inc. - Opportunities
Opportunity - Demographic Trends
Opportunity - Strategic Agreements
Opportunity - Promising Product Pipeline
Arno Therapeutics, Inc. - Threats
Threat - Competitive Pressures
Threat - Product Liability Claims
Threat - Stringent Government Regulations
Arno Therapeutics, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Arno Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Arno Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Arno Therapeutics, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
May 16, 2016: Arno Therapeutics Reports First Quarter 2016 Financial and Business Update
Mar 30, 2016: Arno Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update
Nov 16, 2015: Arno Therapeutics Reports Third Quarter 2015 Financial Results and Business Update
Aug 14, 2015: Arno Therapeutics Reports Second Quarter 2015 Financial Results
May 15, 2015: Arno Therapeutics Reports First Quarter 2015 Financial and Business Update
Mar 31, 2015: Arno Therapeutics Reports Fourth Quarter 2014 Financial and Business Update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Arno Therapeutics, Inc., Key Facts
Arno Therapeutics, Inc., Key Employees
Arno Therapeutics, Inc., Key Employee Biographies
Arno Therapeutics, Inc., Major Products and Services
Arno Therapeutics, Inc., Number of Pipeline Products by Therapy Area
Arno Therapeutics, Inc., Number of Pipeline Products by Development Stage
Arno Therapeutics, Inc., Pipeline Products By Therapy Area and Development Phase
Arno Therapeutics, Inc., History
Arno Therapeutics, Inc., Key Competitors
Arno Therapeutics, Inc., Ratios based on current share price
Arno Therapeutics, Inc., Annual Ratios
Arno Therapeutics, Inc., Interim Ratios
Arno Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Arno Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Arno Therapeutics, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Arno Therapeutics, Inc., Pipeline Products by Therapy Area
Arno Therapeutics, Inc., Pipeline Products by Development Phase
Arno Therapeutics, Inc., Performance Chart (2011 - 2015)
Arno Therapeutics, Inc., Ratio Charts
Arno Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Arno Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report